Evidence map›Paper›PMID 39592720›Full record

ArticleScientific reports2024

Impact of a two step antimicrobial stewardship program in a paediatric haematology and oncology unit.

Cecilia Liberati, Elisa Barbieri, Francesca Cavagnero, Maria Grazia Petris, Giulia Brigadoi, Giulia Reggiani, Marica De Pieri, Marta Pierobon, Antonio Marzollo, Maria Gabelli and 12 more

Abstract read
In one paragraph

Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Observational
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Cecilia Liberati *Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Via Giustiniani 3 Padua, 35141, Padova, Italy. cecilia.liberati@unipd.it.
Elisa Barbieri *Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Via Giustiniani 3 Padua, 35141, Padova, Italy.
Francesca CavagneroDivision of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Via Giustiniani 3 Padua, 35141, Padova, Italy.
Maria Grazia PetrisPaediatric Haematology, Oncology and Stem Cell Transplant, Padua University Hospital, Padua, Italy.
Giulia BrigadoiDivision of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Via Giustiniani 3 Padua, 35141, Padova, Italy.
Giulia ReggianiPaediatric Haematology, Oncology and Stem Cell Transplant, Padua University Hospital, Padua, Italy.
Marica De PieriDivision of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Via Giustiniani 3 Padua, 35141, Padova, Italy.
Marta PierobonPaediatric Haematology, Oncology and Stem Cell Transplant, Padua University Hospital, Padua, Italy.
Antonio MarzolloPaediatric Haematology, Oncology and Stem Cell Transplant, Padua University Hospital, Padua, Italy.
Maria GabelliPaediatric Haematology, Oncology and Stem Cell Transplant, Padua University Hospital, Padua, Italy.
Sabrina TrivellatoHospital Pharmacy Unit, Azienda Ospedale-Università di Padova, Padua, Italy.
Erika RigottiDepartment of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.
Francesca OpriDepartment of Surgical Sciences, Dentistry, Gynecology and Pediatrics, Pediatric Clinic, University of Verona, Verona, Italy.
Daniele MengatoHospital Pharmacy Unit, Azienda Ospedale-Università di Padova, Padua, Italy.
Francesca VenturiniHospital Pharmacy Unit, Azienda Ospedale-Università di Padova, Padua, Italy.
Ettore De CanaleMicrobiology and Virology Unit, Padua University Hospital, Padua, Italy.
Claudia Del VecchioMicrobiology and Virology Unit, Padua University Hospital, Padua, Italy.
Carlo GiaquintoDivision of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Via Giustiniani 3 Padua, 35141, Padova, Italy.
Elena CarraraDivision of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
Evelina TacconelliDivision of Infectious Diseases, Department of Diagnostic and Public Health, University of Verona, Verona, Italy.
Alessandra Biffi *Division of Paediatric Haematology, Oncology and Stem Cell Transplant, Department for Women's and Children's Health, University of Padova, Padova, Italy.
Daniele Donà *Division of Paediatric Infectious Diseases, Department of Women's and Children's Health, University of Padova, Via Giustiniani 3 Padua, 35141, Padova, Italy.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo describe the implementation of a multi-step antimicrobial stewardship program in a haemato-oncology and stem cell transplantation program unit. Methods: Pre-post quasi-experimental study with two interrupted time-series analyses, conducted between 01/01/2019 and 31/12/2022 in the Paediatric Haemato-Oncology Unit of the Padua Paediatric Hospital. The interventions were: (1) 02/2020: dissemination of febrile neutropenia clinical pathways, (2) April 2021: provision of the clinical pathways via a customized App (Firstline.org) and implementation of a twice-a-week prospective audit and feedback. The main outcome was antibiotic consumption measured by days of administered therapy (DOTs)/1000 patients' days for all antibiotics and most used molecules.

resultsThe first intervention (clinical pathways) resulted in a decrease in the overall antibiotic use by the haemato-oncology unit, with an abrupt reduction of 3-gen cephalosporins in favor of piperacillin-tazobactam, as indicated by the clinical pathways. Meropenem and glycopeptide use did not vary. The second intervention (antimicrobial stewardship) further decreased total antibiotic consumption, and a significant decline in meropenem, amikacin, and glycopeptides was achieved.

conclusionsMulti-step stewardship based on guidelines dissemination, multidisciplinary team intervention and collaboration ("handshake" stewardship) was highly effective in optimizing guidelines adherence and reducing overprescriptions in a fragile patient cohort.

Indexed as

Anti-Bacterial AgentsAntimicrobial StewardshipChildChild, PreschoolCritical PathwaysFemaleHematologyHospitals, PediatricHumansInterrupted Time Series AnalysisMaleMedical OncologyAnti-Bacterial AgentsAntibiotics.Antimicrobial stewardshipPediatric Oncology HaematologyStem cell transplantation

Identifiers

PMID39592720
PMCPMC11599578

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.